GCL
AVEO

Glazer Capital LLC’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Glazer Capital LLC’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-62,066
Closed -$928K – 581
2022
Q4 		$928K Buy
+62,066
New +$859K 0.02% 286

Glazer Capital LLC's AVEO Position: Q1 2023 in Review

Glazer Capital LLC sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 62,066 shares — an estimated $928K sold.

Glazer Capital LLC first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $928K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Glazer Capital LLC reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Glazer Capital LLC sold 62,066 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $928K.
  • Glazer Capital LLC first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Glazer Capital LLC's AVEO Pharmaceuticals, Inc. position peaked at $928K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Glazer Capital LLC's 13F filing for Q1 2023, filed 15 May 2023.